EU Leaders Doubt Proposal for Waivers on Intellectual Property Rights for Vaccines

BioNTech also weighed in on the vaccine patent waiver debate on Monday. It says there’s no need to waive the patents because manufacturers will be able to produce enough shots for the world over the coming year.

ntd newsletter icon
Sign up for NTD Daily
What you need to know, summarized in one email.
Stay informed with accurate news you can trust.
By registering for the newsletter, you agree to the Privacy Policy.
Comments